• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADCYAP1,即腺苷酸环化酶激活肽 1,作为一种甲基化生物标志物,可用于宫颈癌的早期检测。

The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer.

机构信息

Division of Biological Science and Research Center for Women's Diseases, Sookmyung Women's University, Seoul, Korea.

出版信息

Oncol Rep. 2011 Jan;25(1):245-52.

PMID:21109983
Abstract

The ADCYAP1 gene encodes an adenylate cyclase activating polypeptide 1. ADCYAP1 has been known to be involved in various biological processes. Multiple cytosine guanine dinucleotides (CpG island) are found in the ADCYAP1 promoter region. Transcriptional silencing by promoter hypermethylation is an important regulatory mechanism in tumorigenesis in many cancers. Therefore, the methylation level of the ADCYAP1 promoter was investigated in eight cervical cancer cell lines and human tissue samples with a distinctive degree of malignant transformation. While multiple CpG sites in the ADCYAP1 promoter were highly methylated in CIN III and invasive carcinoma cells as well as seven cervical cancer cell lines, they were rarely methylated in normal cells. Importantly, methylation in the ADCYAP1 promoter seems to start from CIN I, relatively early stage of multistep carcinogenesis. This fact suggest that ADCYAP1 can be used as an effective and sensitive methylation biomarker for the early diagnosis of cervical cancer. Moreover, our data imply that the level of the ADCYAP1 promoter hypermethylation is correlated with cervical cancer development. We also show that ADCYAP1 gene expression was reactivated by the treatment of a DNA methyltransferase inhibitor of 5'-aza-2'deoxycytidine and/or a histone deacetylase inhibitor of trichostain A in cervical cancer cells suggesting that hypermethylation in the ADCYAP1 promoter is responsible for the transcriptional silencing of the ADCYAP1 gene in cervical cancer cells.

摘要

ADCYAP1 基因编码一种腺苷酸环化酶激活多肽 1。ADCYAP1 已知参与多种生物过程。ADCYAP1 启动子区域存在多个胞嘧啶鸟嘌呤二核苷酸(CpG 岛)。启动子超甲基化导致转录沉默是许多癌症中肿瘤发生的重要调节机制。因此,研究了 8 种宫颈癌细胞系和具有不同恶性转化程度的人组织样本中 ADCYAP1 启动子的甲基化水平。虽然在 CIN III 和浸润性癌细胞以及 7 种宫颈癌细胞系中,ADCYAP1 启动子的多个 CpG 位点高度甲基化,但在正常细胞中很少甲基化。重要的是,ADCYAP1 启动子的甲基化似乎从 CIN I 开始,即多步骤致癌作用的相对早期阶段。这一事实表明,ADCYAP1 可以作为宫颈癌早期诊断的有效和敏感的甲基化生物标志物。此外,我们的数据表明,ADCYAP1 启动子高甲基化水平与宫颈癌的发展相关。我们还表明,在宫颈癌细胞中,5'-氮杂-2'-脱氧胞苷的 DNA 甲基转移酶抑制剂和/或曲古抑菌素 A 的组蛋白去乙酰化酶抑制剂的处理可以重新激活 ADCYAP1 基因的表达,表明 ADCYAP1 启动子的高甲基化导致了宫颈癌细胞中 ADCYAP1 基因的转录沉默。

相似文献

1
The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer.ADCYAP1,即腺苷酸环化酶激活肽 1,作为一种甲基化生物标志物,可用于宫颈癌的早期检测。
Oncol Rep. 2011 Jan;25(1):245-52.
2
IGSF4 promoter methylation and expression silencing in human cervical cancer.人宫颈癌中IGSF4启动子甲基化与表达沉默
Gynecol Oncol. 2005 Jan;96(1):150-8. doi: 10.1016/j.ygyno.2004.08.050.
3
Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.Wnt抑制因子-1在人类胃肠道癌症中频繁发生表观遗传失活。
Oncogene. 2005 Nov 24;24(53):7946-52. doi: 10.1038/sj.onc.1208910.
4
Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells.人白细胞介素10基因在宫颈癌细胞中通过启动子甲基化实现谱系特异性沉默。
Eur J Cancer. 2008 May;44(7):1030-8. doi: 10.1016/j.ejca.2008.02.046. Epub 2008 Apr 18.
5
Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.早期胃腺癌及癌前病变中多个基因的启动子高甲基化
Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19.
6
DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.DNA甲基化模式转变:非典型启动子高甲基化导致前列腺上皮内瘤变和前列腺癌中15-脂氧合酶-1上调。
Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):185-97. doi: 10.1016/j.prostaglandins.2006.05.015. Epub 2006 Jul 11.
7
OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.OPCML基因启动子甲基化及在浸润性宫颈癌肿瘤细胞和基质细胞中的基因表达
Cancer Invest. 2008 Jul;26(6):569-74. doi: 10.1080/07357900701837044.
8
Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.儿茶酚-O-甲基转移酶基因的多个启动子在子宫内膜癌中因CpG高甲基化而被选择性失活。
Cancer Res. 2003 Jun 15;63(12):3101-6.
9
Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.子宫颈癌中POU2F3基因的异常启动子甲基化与沉默
Oncogene. 2006 Aug 31;25(39):5436-45. doi: 10.1038/sj.onc.1209530. Epub 2006 Apr 10.
10
Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation.通过启动子甲基化导致鼻咽癌中CHFR基因的表观遗传失活。
Mol Carcinog. 2005 Aug;43(4):237-45. doi: 10.1002/mc.20106.

引用本文的文献

1
ADCYAP1 as a pan-solid cancer biomarker: predictor of immunotherapy efficacy in bladder cancer and prognostic potential across solid tumors.ADCYAP1作为一种泛实体癌生物标志物:膀胱癌免疫治疗疗效的预测指标及实体瘤的预后潜力
Discov Oncol. 2025 Apr 23;16(1):593. doi: 10.1007/s12672-025-02408-3.
2
Gene Expression Analysis for Uterine Cervix and Corpus Cancer Characterization.子宫颈和子宫体癌的基因表达分析。
Genes (Basel). 2024 Feb 28;15(3):312. doi: 10.3390/genes15030312.
3
The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy.
组蛋白去乙酰化酶抑制剂在宫颈癌治疗中的新兴作用
Cancers (Basel). 2023 Apr 10;15(8):2222. doi: 10.3390/cancers15082222.
4
Dysregulation of Circadian Clock Genes Associated with Tumor Immunity and Prognosis in Patients with Colon Cancer.生物钟基因失调与结肠癌患者的肿瘤免疫和预后相关。
Comput Math Methods Med. 2022 Jul 16;2022:4957996. doi: 10.1155/2022/4957996. eCollection 2022.
5
Epigenetic Modifier Supplementation Improves Mitochondrial Respiration and Growth Rates and Alters DNA Methylation of Bovine Embryonic Fibroblast Cells Cultured in Divergent Energy Supply.补充表观遗传修饰剂可改善线粒体呼吸和生长速率,并改变在不同能量供应条件下培养的牛胚胎成纤维细胞的DNA甲基化。
Front Genet. 2022 Feb 24;13:812764. doi: 10.3389/fgene.2022.812764. eCollection 2022.
6
Prognostic prediction of a 12-methylation gene-based risk score system on pancreatic adenocarcinoma.基于12个甲基化基因的风险评分系统对胰腺腺癌的预后预测
Oncol Lett. 2020 Jul;20(1):85-98. doi: 10.3892/ol.2020.11575. Epub 2020 Apr 27.
7
PACAP and PAC1 receptor expression in pancreatic ductal carcinoma.垂体腺苷酸环化酶激活肽及PAC1受体在胰腺导管癌中的表达
Oncol Lett. 2019 Dec;18(6):5725-5730. doi: 10.3892/ol.2019.10971. Epub 2019 Oct 8.
8
Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.垂体腺苷酸环化酶激活多肽:30年处于研究焦点,6亿年发挥作用。
J Clin Med. 2019 Sep 18;8(9):1488. doi: 10.3390/jcm8091488.
9
Peptide receptors as cancer drug targets.肽受体作为癌症药物靶点。
Ann N Y Acad Sci. 2019 Nov;1455(1):141-148. doi: 10.1111/nyas.14100. Epub 2019 May 10.
10
Transcriptomics analysis reveals new insights in E171-induced molecular alterations in a mouse model of colon cancer.转录组学分析揭示了 E171 在结肠癌小鼠模型中诱导的分子变化的新见解。
Sci Rep. 2018 Jun 27;8(1):9738. doi: 10.1038/s41598-018-28063-z.